Evidence map›Paper›PMID 38760415›Full record

ArticleScientific reports2024

Prevalence of hepatitis B and C viruses among migrant workers in Qatar.

Gheyath K Nasrallah, Hiam Chemaitelly, Ahmed I A Ismail, Parveen B Nizamuddin, Duaa W Al-Sadeq, Farah M Shurrab, Fathima H Amanullah, Tasneem H Al-Hamad, Khadija N Mohammad, Maryam A Alabdulmalek and 47 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

57 authors.

Gheyath K NasrallahBiomedical Research Center, Qatar University, Doha, Qatar. gheyath.nasrallah@qu.edu.qa.ORCID 0000-0001-9252-1038
Hiam ChemaitellyInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, P.O. Box 24144, Doha, Qatar.ORCID 0000-0002-8756-6968
Ahmed I A IsmailLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.ORCID 0000-0003-0102-8155
Parveen B NizamuddinBiomedical Research Center, Qatar University, Doha, Qatar.
Duaa W Al-SadeqBiomedical Research Center, Qatar University, Doha, Qatar.
Farah M ShurrabBiomedical Research Center, Qatar University, Doha, Qatar.
Fathima H AmanullahBiomedical Research Center, Qatar University, Doha, Qatar.
Tasneem H Al-HamadBiomedical Research Center, Qatar University, Doha, Qatar.
Khadija N MohammadBiomedical Research Center, Qatar University, Doha, Qatar.
Maryam A AlabdulmalekBiomedical Research Center, Qatar University, Doha, Qatar.
Reham A Al KahloutBiomedical Research Center, Qatar University, Doha, Qatar.
Ibrahim Al-ShaarLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
Manal A ElshaikhLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
Mazen N AbouassaliLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
Ibrahim W KarimehLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
Mutaz M AliLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
Houssein H AyoubMathematics Program, Department of Mathematics and Statistics, College of Arts and Sciences, Qatar University, Doha, Qatar.ORCID 0000-0003-2512-6657
Sami AbdeenHamad Medical Corporation, Doha, Qatar.
Ashraf AbdelkarimHamad Medical Corporation, Doha, Qatar.
Faisal DaraanMinistry of Public Health, Doha, Qatar.
Ahmed Ibrahim Hashim Elhaj IsmailMinistry of Public Health, Doha, Qatar.
Nahid MostafaMinistry of Public Health, Doha, Qatar.
Mohamed SahlHamad Medical Corporation, Doha, Qatar.
Jinan SulimanHamad Medical Corporation, Doha, Qatar.
Elias TayarHamad Medical Corporation, Doha, Qatar.
Hasan Ali KasemQatar Red Crescent Society, Doha, Qatar.
Meynard J A AgsalogQatar Red Crescent Society, Doha, Qatar.
Bassam K AkkarathodiyilQatar Red Crescent Society, Doha, Qatar.
Ayat A AlkhalafQatar Red Crescent Society, Doha, Qatar.
Mohamed Morhaf M H AlaksharQatar Red Crescent Society, Doha, Qatar.
Abdulsalam Ali A H Al-QahtaniQatar Red Crescent Society, Doha, Qatar.
Monther H A Al-ShedifatQatar Red Crescent Society, Doha, Qatar.
Anas AnsariQatar Red Crescent Society, Doha, Qatar.
Ahmad Ali AtaallaQatar Red Crescent Society, Doha, Qatar.
Sandeep ChouguleQatar Red Crescent Society, Doha, Qatar.
Abhilash K K V GopinathanQatar Red Crescent Society, Doha, Qatar.
Feroz J PoolakundanQatar Red Crescent Society, Doha, Qatar.
Sanjay U RanbhiseQatar Red Crescent Society, Doha, Qatar.
Saed M A SaefanQatar Red Crescent Society, Doha, Qatar.
Mohamed M ThaivalappilQatar Red Crescent Society, Doha, Qatar.
Abubacker S ThoyalilQatar Red Crescent Society, Doha, Qatar.
Inayath M UmarQatar Red Crescent Society, Doha, Qatar.
Einas Al KuwariHamad Medical Corporation, Doha, Qatar.
Peter CoyleBiomedical Research Center, Qatar University, Doha, Qatar.
Andrew JeremijenkoHamad Medical Corporation, Doha, Qatar.
Anvar Hassan KaleeckalHamad Medical Corporation, Doha, Qatar.
Hanan F Abdul RahimDepartment of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Hadi M YassineBiomedical Research Center, Qatar University, Doha, Qatar.
Asmaa A Al ThaniBiomedical Research Center, Qatar University, Doha, Qatar.
Odette ChaghouryHamad Medical Corporation, Doha, Qatar.
Mohamed Ghaith Al KuwariPrimary Health Care Corporation, Doha, Qatar.
Elmoubasher FaragMinistry of Public Health, Doha, Qatar.
Roberto BertolliniMinistry of Public Health, Doha, Qatar.
Hamad Eid Al RomaihiMinistry of Public Health, Doha, Qatar.
Abdullatif Al KhalHamad Medical Corporation, Doha, Qatar.
Mohamed H Al-ThaniMinistry of Public Health, Doha, Qatar.
Laith J Abu-RaddadInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, P.O. Box 24144, Doha, Qatar. lja2002@qatar-med.cornell.edu.ORCID 0000-0003-0790-0506

Funding

Qatar National Research Fund NPRP grant number 12S-0216-190094Qatar Research, Development and Innovation (QRDI) Council UREP30-041-3-014Qatar University QUCG-CAS-23/24-114Weill Cornell Medicine - Qatar Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core
6 · The paper itself

Abstract

Limited data exist on viral hepatitis among migrant populations. This study investigated the prevalence of current hepatitis B virus (HBV) infection and lifetime hepatitis C virus (HCV) infection among Qatar's migrant craft and manual workers (CMWs), constituting 60% of the country's population. Sera collected during a nationwide COVID-19 population-based cross-sectional survey on CMWs between July 26 and September 9, 2020, underwent testing for HBsAg and HCV antibodies. Reactive samples underwent confirmatory testing, and logistic regression analyses were employed to explore associations with HBV and HCV infections. Among 2528 specimens tested for HBV infection, 15 were reactive, with 8 subsequently confirmed positive. Three samples lacked sufficient sera for confirmatory testing but were included in the analysis through multiple imputations. Prevalence of current HBV infection was 0.4% (95% CI 0.2-0.7%). Educational attainment and occupation were significantly associated with current HBV infection. For HCV infection, out of 2607 specimens tested, 46 were reactive, and 23 were subsequently confirmed positive. Prevalence of lifetime HCV infection was 0.8% (95% CI 0.5-1.2%). Egyptians exhibited the highest prevalence at 6.5% (95% CI 3.1-13.1%), followed by Pakistanis at 3.1% (95% CI 1.1-8.0%). Nationality, geographic location, and occupation were significantly associated with lifetime HCV infection. HBV infection is relatively low among CMWs, while HCV infection falls within the intermediate range, both compared to global and regional levels.

Indexed as

Hepatitis BHepatitis CTransients and MigrantsAdolescentAdultCOVID-19Cross-Sectional StudiesFemaleHepacivirusHepatitis B Surface AntigensHepatitis B virusHepatitis C AntibodiesHumansMaleMiddle AgedPrevalenceHepatitis B Surface AntigensHepatitis C AntibodiesCross-sectionalHBVHCVHepatitisInfectionPrevalenceQatarWorkers

Identifiers

PMID38760415
PMCPMC11101619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.